Form SC 13D/A - General Statement of Acquisition of Beneficial Ownership: [Amend]
SEC Accession No. 0000898432-20-000701
Filing Date
2020-08-05
Accepted
2020-08-05 09:23:16
Documents
1
Group Members
22NW FUND, GP, LLC22NW FUND, L.P.22NW GP, INC.ARON R. ENGLISH

Document Format Files

Seq Description Document Type Size
1 sc13d.htm SC 13D/A 133972
  Complete submission text file 0000898432-20-000701.txt   135631
Mailing Address 611 GATEWAY BLVD., SUITE 710 SOUTH SAN FRANCISCO CA 94080
Business Address 611 GATEWAY BLVD., SUITE 710 SOUTH SAN FRANCISCO CA 94080 650-871-0761
CATALYST BIOSCIENCES, INC. (Subject) CIK: 0001124105 (see all company filings)

EIN.: 562020050 | Fiscal Year End: 1231
Type: SC 13D/A | Act: 34 | File No.: 005-82442 | Film No.: 201075923
SIC: 2834 Pharmaceutical Preparations

Mailing Address 1455 NW LEARY WAY, SUITE 400 SEATTLE WA 98107
Business Address 1455 NW LEARY WAY, SUITE 400 SEATTLE WA 98107 206-437-9174
22NW, LP (Filed by) CIK: 0001694297 (see all company filings)

EIN.: 473089159 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13D/A